Renal/Urology · PANCE / PANRE

Hyponatremia

Serum Na <135 mEq/L; evaluated by volume status and urine osmolality/sodium.

Also known as: hyponatremia, low sodium, SIADH

Overview

Serum sodium concentration <135 mEq/L. Classified by severity (mild 130-134, moderate 125-129, severe <125), acuity (acute <48 h vs chronic), tonicity (hypotonic — true hyponatremia — vs isotonic vs hypertonic pseudohyponatremia), and volume status (hypovolemic, euvolemic, hypervolemic).

Epidemiology

Most common electrolyte abnormality in hospitalized patients (~15-20%). Associated with increased morbidity, mortality, and length of stay across populations.

🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Hyponatremia outline — plus all 514 diagnoses, 3,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Free to start · No credit card · Cancel anytime

Risk factors

  • Diuretic use, especially thiazides (HCTZ, chlorthalidone)
  • SIADH triggers: malignancy (small cell lung), CNS disease (stroke, hemorrhage, infection), pulmonary disease (pneumonia, TB), drugs (SSRIs, carbamazepine, MDMA, antipsychotics)
  • Heart failure, cirrhosis, nephrotic syndrome (effective arterial underfilling)
  • Adrenal insufficiency, hypothyroidism
  • Polydipsia (psychogenic, beer potomania, tea-and-toast)
  • Postoperative, hypotonic IV fluid administration
  • Exercise-associated hyponatremia (marathon runners over-hydrating with hypotonic fluids)

Pathophysiology

True hypotonic hyponatremia results from excess water relative to sodium. ADH-driven water retention exceeds urinary water excretion capacity. Causes are categorized by volume status: hypovolemic (volume loss replaced with hypotonic fluid), euvolemic (SIADH, hypothyroid, adrenal insufficiency), hypervolemic (HF, cirrhosis, CKD/nephrotic — total body Na increased but water more so). Pseudohyponatremia: severe hyperlipidemia or hyperproteinemia causes lab artifact with normal plasma water Na.

Clinical presentation

Symptoms

  • Mild (130-134): often asymptomatic
  • Moderate (125-129): nausea, headache, fatigue, gait instability
  • Severe (<120 or rapid drop): confusion, seizures, coma, respiratory arrest
  • Symptoms more prominent in ACUTE hyponatremia (rapid decrease); chronic patients may tolerate lower levels

Signs / physical exam

  • Volume status assessment is central to diagnosis
  • Hypovolemic: dry mucous membranes, orthostasis, flat JVP
  • Euvolemic: normal volume exam
  • Hypervolemic: edema, elevated JVP, ascites, crackles
  • Neurologic: altered mental status, focal deficits, hyperreflexia, seizure activity in severe cases

Classic findings

Acute hyponatremia <120 with altered mental status or seizures = emergency requiring 3% hypertonic saline.

Differential diagnosis

  • Hypovolemic hyponatremia — Volume depletion + low urine Na (<20) + high urine osm; GI losses, diuretics (high urine Na if active), bleeding
  • SIADH (euvolemic) — Normal volume, low serum osm, INAPPROPRIATELY concentrated urine (osm >100), urine Na >40, normal thyroid/adrenal function
  • Hypothyroidism / adrenal insufficiency — Test TSH, cortisol; mimic SIADH labs; correct hormone deficit
  • Polydipsia / low solute intake — Dilute urine (<100 mOsm/kg), high water intake (psychogenic) or low solute (beer potomania)
  • Hypervolemic hyponatremia — Edema, ascites; HF, cirrhosis, nephrotic syndrome; urine Na <20 (except CKD)
  • Pseudohyponatremia — Severe hyperlipidemia, hyperproteinemia (multiple myeloma); normal measured osmolality
  • Translocational hyponatremia — Hyperglycemia, mannitol; correct Na = measured Na + 1.6 × ((glucose - 100)/100)

Diagnostic workup

Diagnostic criteria

Serum Na <135 + serum osm <275 = true hypotonic hyponatremia. Etiology determined by volume status + urine osmolality + urine Na (algorithmic approach).

Labs

  • Confirm true hypotonic hyponatremia: measure serum osmolality (low <275 mOsm/kg in true; normal in pseudohyponatremia; high in hyperglycemia or mannitol)
  • Urine osmolality — <100 = primary polydipsia or low solute; >100 = ADH-driven
  • Urine sodium — <20 = volume depletion or low effective volume (HF, cirrhosis); >40 = SIADH, salt-wasting, diuretic, adrenal insufficiency
  • Volume status assessment (clinical exam)
  • TSH, cortisol (or cosyntropin stimulation) to rule out hypothyroidism and adrenal insufficiency
  • BMP for renal function, glucose; uric acid (low in SIADH, high in cerebral salt wasting)

Imaging

  • Chest CT if SIADH suspected to evaluate for malignancy (especially small cell lung)
  • Brain MRI if CNS process suspected as cause

Diagnostic algorithm

flowchart TD
  A[Serum Na <135] --> B[Serum osmolality]
  B -->|Normal/High| C[Pseudohyponatremia<br/>or hyperglycemia/mannitol]
  B -->|Low <275| D[True hypotonic<br/>hyponatremia]
  D --> E[Assess volume status]
  E -->|Hypovolemic| F[Urine Na]
  F -->|<20| G[Extrarenal loss<br/>GI, skin, blood]
  F -->|>40| H[Renal loss<br/>diuretic, adrenal insuff]
  E -->|Euvolemic| I[Urine osm]
  I -->|<100| J[Primary polydipsia<br/>low solute]
  I -->|>100| K[SIADH, hypothyroid,<br/>adrenal insuff]
  E -->|Hypervolemic| L[HF, cirrhosis,<br/>nephrotic, CKD]
Diagnostic algorithm for hyponatremia — serum osmolality, then volume status, then urine studies.

Treatment

First-line

  • Severe symptomatic (seizures, coma, focal neuro deficits):
  • 3% hypertonic saline 100 mL IV bolus, may repeat × 2 every 10 min until symptoms improve; goal is +4-6 mEq/L rise to relieve symptoms
  • Maximum correction 8-10 mEq/L per 24 h (some experts allow up to 12 mEq/L); slower in chronic, malnourished, alcoholic, or hypokalemic patients to avoid osmotic demyelination
  • Treat underlying cause once stable
  • Hypovolemic hyponatremia: isotonic saline (normal saline or lactated Ringer's)
  • Euvolemic hyponatremia (SIADH): fluid restriction (<800-1000 mL/day) first-line; salt tablets or urea if persistent
  • Hypervolemic hyponatremia: fluid + sodium restriction; loop diuretic (furosemide, torsemide); treat underlying HF or cirrhosis
  • Stop offending medications (thiazides, SSRIs)

Second-line / adjunct

  • Vasopressin receptor antagonists (vaptans): tolvaptan (oral), conivaptan (IV) — for refractory SIADH or hypervolemic hyponatremia; monitor closely due to risk of rapid correction
  • Demeclocycline (induces nephrogenic DI) — historical SIADH therapy, rarely used now
  • Treat underlying cause: replace cortisol/thyroid hormone, treat malignancy, manage HF/cirrhosis
  • If overcorrection occurs (Na rises >10-12 mEq/L in 24 h): re-lower with D5W ± DDAVP to prevent osmotic demyelination

Complications

  • Osmotic demyelination syndrome (formerly central pontine myelinolysis) — from overly rapid correction; presents days later with dysarthria, dysphagia, paraparesis, locked-in syndrome; irreversible
  • Cerebral edema and herniation from severe acute hyponatremia
  • Seizures
  • Falls and fractures (chronic mild hyponatremia)
  • Increased mortality in hospitalized patients

PANCE pearls

  • First step in hyponatremia evaluation: check serum osmolality. Low (<275) = true hypotonic; normal = pseudohyponatremia; high = translocational (hyperglycemia, mannitol).
  • SIADH diagnostic criteria: hypotonic hyponatremia + euvolemia + urine osm >100 + urine Na >40 + normal thyroid and adrenal function + no diuretics.
  • Correct chronic hyponatremia SLOWLY: max 8-10 mEq/L per 24 hours to avoid osmotic demyelination syndrome. Higher-risk patients (alcoholics, malnourished, hypokalemic): even more cautious.
  • Acute symptomatic hyponatremia (<48 h): 3% hypertonic saline is appropriate emergency treatment regardless of chronicity concerns.
  • Pseudohyponatremia clue: normal serum osmolality despite low measured Na (lab artifact from hypertriglyceridemia, hyperproteinemia).
  • Hyperglycemia correction formula: corrected Na = measured Na + 1.6 × ((glucose − 100)/100). Each 100 mg/dL glucose rise lowers Na ~1.6 mEq/L.

References

  • European Society 2014 — Clinical practice guideline on diagnosis and treatment of hyponatraemia (Spasovski et al., Eur J Endocrinol 2014)
  • Expert Panel 2013 — Diagnosis, Evaluation, and Treatment of Hyponatremia: Expert Panel Recommendations (Verbalis et al., Am J Med 2013)

Practice Renal/Urology questions on FirstPassPA

Turn this outline into retention. 3,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Start studying free → Browse all 514 diagnoses

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants.